Dermapharm Holding SE | WebDisclosure

Basculer en Français

11334	Companies
251920	Keywords
181210	Articles
137706	Press releases

Headlines Articles Press releases Dermapharm Holding SE

Home
Companies
Dermapharm Holding SE

PRESS RELEASE

published on 11/14/2024 at 07:30, 1 year 11 months ago

Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time
Dermapharm Holding SE reports strong Q3 2024 results with consolidated revenue up 2.7% to EUR 890.1 million. Adjusted EBITDA margin improves. Outlook confirms forecasted targets for 2024

Revenue Growth Adjusted EBITDA Margin Q3 2024 Dermapharm Holding SE Results
BRIEF

published on 08/27/2024 at 07:35, 2 years 2 months ago

Dermapharm Holding SE: Strong Branded Pharmaceuticals Segment Fuels Organic Growth

EBITDA 2024 Outlook Organic Growth Branded Pharmaceuticals Dermapharm
BRIEF

published on 08/27/2024 at 07:35, 2 years 2 months ago

Dermapharm Holding SE : un segment de produits pharmaceutiques de marque solide alimente la croissance organique

EBITDA Croissance Organique Perspectives 2024 Produits Pharmaceutiques De Marque Dermapharm
PRESS RELEASE

published on 08/27/2024 at 07:30, 2 years 2 months ago

Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies
Dermapharm Holding SE reports 7.3% rise in unadjusted EBITDA to EUR 147.0 million, driven by organic growth in branded pharmaceuticals segment. High-revenue expected in H2. Full report at https://ir.dermapharm.de/en

EBITDA Revenue Forecast Organic Growth Dermapharm Holding SE Branded Pharmaceuticals
BRIEF

published on 08/14/2024 at 07:35, 2 years 2 months ago

Croissance organique soutenue dans le secteur pharmaceutique à forte marge

EBITDA Médicaments Revenu Dermapharm Premier Semestre 2024
BRIEF

published on 08/14/2024 at 07:35, 2 years 2 months ago

Sustained Organic Growth in High-Margin Pharmaceutical Business

EBITDA Revenue Pharmaceuticals H1 2024 Dermapharm
PRESS RELEASE

published on 08/14/2024 at 07:30, 2 years 2 months ago

Sustained organic growth in high-margin existing branded pharmaceutical business
Dermapharm Holding SE reports sustained organic growth in high-margin existing branded pharmaceutical business, with year-on-year drop in revenue and EBITDA in first half of 2024

Financial Results 2024 Outlook Organic Growth Dermapharm Holding SE Branded Pharmaceuticals
BRIEF

published on 06/27/2024 at 18:20, 2 years 4 months ago

Dermapharm Holding SE : l'Assemblée générale annuelle décide de distribuer un dividende de 0,88 EUR par action

Dividende Assemblée Générale Annuelle Perspectives Financières Dermapharm
BRIEF

published on 06/27/2024 at 18:20, 2 years 4 months ago

Dermapharm Holding SE: Annual General Meeting Resolves Dividend Distribution of EUR 0.88 Per Share

Annual General Meeting Dividend Financial Outlook Dermapharm
PRESS RELEASE

published on 06/27/2024 at 18:15, 2 years 4 months ago

Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Dermapharm Holding SE's Annual General Meeting approves EUR 0.88 per share dividend distribution for 2024. Board actions confirmed. Outlook and acquisitions strategies highlighted

Annual General Meeting Acquisitions Outlook Dividend Distribution Dermapharm Holding SE

Accesswire

Published on 11/13/2026 at 14:00, 36 minutes ago

GameSquare's Hatchet Publishes TikTok Live for Gaming in H1 2026 Report
Published on 11/13/2026 at 13:30, 1 hour 6 minutes ago

Mako Mining Reports Q3 2026 Financial Results, Including Adjusted EBITDA(1) of US$30.3 million and EPS of US$0.19/share
Published on 11/13/2026 at 13:30, 1 hour 6 minutes ago

Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q2
Published on 11/13/2026 at 10:40, 3 hours 56 minutes ago

SouthGobi Announces Third Quarter 2026 Unaudited Financial and Operating Results
Published on 11/13/2026 at 09:00, 5 hours 36 minutes ago

Touchstone Exploration Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/13/2026 at 14:18, 17 minutes ago

XTPL raises PLN 26 million through Series Z share issue, with Taiwania CEE Fund joining the Company’s shareholder base
Published on 11/13/2026 at 13:30, 1 hour 6 minutes ago

Cemig and Huawei Jointly Deploy 450 MHz Private Wireless Network
Published on 11/13/2026 at 13:30, 1 hour 6 minutes ago

Holding(s) in Company
Published on 11/13/2026 at 12:30, 2 hours 6 minutes ago

WIN SOURCE Highlights NEXUS™ at electronica 2026, Advancing Supply Chain Resilience
Published on 11/13/2026 at 12:30, 2 hours 6 minutes ago

Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Les Echos

Published on 11/13/2026 at 11:35, 3 hours 1 minute ago

ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 3 hours 1 minute ago

ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 6 hours 36 minutes ago

Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 15 hours 23 minutes ago

Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 15 hours 23 minutes ago

Belgrano poursuit la mise en oeuvre de son projet d'OPRA

View all LES ECHOS COMFI WIRE